CN102670972B - Drug for treating reflux gastritis and production method thereof - Google Patents
Drug for treating reflux gastritis and production method thereof Download PDFInfo
- Publication number
- CN102670972B CN102670972B CN201210120673.1A CN201210120673A CN102670972B CN 102670972 B CN102670972 B CN 102670972B CN 201210120673 A CN201210120673 A CN 201210120673A CN 102670972 B CN102670972 B CN 102670972B
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- fructus
- rhizoma atractylodis
- reflux gastritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a medicine for treating reflux gastritis and production method thereof, which are characterized by comprising 5g to 15g of ochre, 5g to 15g of Inulicin, 15g to 25g of atractylodes, 15g to 25g of atractylodes macrocephala koidz, 10g to 20g of raw astragalus roots, 10g to 20g of radix codonopsis, 5g to 15g of fructus lycii, 5g to 15g ofcardamom, 5g to 15g of fritillaria thunbergii, 5g to 15g of sepium, 5g to 15g of akebia quinata, 3g to 7g of aspongopus, 5g to 15g of polygonatum kingianum, 3g to 9g of fructus aurantii and 3g to 9g of cortex magnoliae officinalis. The medicine for treating the reflux gastritis is selected and scientific in materials, and is excellent in curative effect to treat the thevreflux gastritis of chronic gastritis. The production method of the medicine for treating the reflux gastritis is simple, and convenient to purchase raw materials.
Description
Technical field:
The present invention relates to a kind of medicine and production method thereof, particularly a kind of medicine and production method thereof for the treatment of reflux gastritis.
Background technology:
Although have various Chinese Traditional Medicines at present, also there is no a kind of medicine for the treatment of reflux gastritis, thereby can not meet the needs of the growing living standard of people.
Summary of the invention:
The object of the invention is to invent a kind of medicine and production method thereof for the treatment of reflux gastritis, this medicine ample supply and prompt delivery, can spleen reinforcing stomach reinforcing, treatment reflux gastritis, in order to overcome, does not treat on the market the deficiency of the medicine of reflux gastritis now.
Object of the present invention can reach by following embodiment: the weight portion of this medicine material is: 5~15 grams of Haematitums, 5~15 grams of Flos Inulae, 15~25 grams of Rhizoma Atractylodis, 15~25 grams of the Rhizoma Atractylodis Macrocephalaes, 10~20 grams of Radix Astragali, 10~20 grams of Radix Codonopsis, 5~15 grams of Fructus Lycii, 5~15 grams of Semen Myristicaes, 5~15 grams of Bulbus Fritillariae Thunbergii, 5~15 grams of Os Sepiae, 5~15 grams of Fructus Akebiaes, 3~7 grams of Aspongopuss, 5~15 grams of Rhizoma Polygonatis, 3~9 grams of Fructus Aurantiis, 3~9 grams of Cortex Magnoliae Officinalis.
Production method of the present invention for will above-mentioned each medicine and together with, 100 degrees Celsius of following oven dry, pulverize, 200 mesh sieves, honey is ball, 9 gram of 1 ball, with yellow waxed paper wrap up patent medicine.
Advantage of the present invention is ample supply and prompt delivery, and carefully selected materials, science can spleen reinforcing stomach reinforcing, treatment reflux gastritis.This method for producing medicines is simple, and raw material is purchased conveniently, is a kind of medicine and production method thereof of good treatment reflux gastritis.
The specific embodiment:
3 embodiment of parts by weight of raw materials of the present invention below:
1, the weight portion of the medicine material of this treatment reflux gastritis is: 5~15 grams of Haematitums, 5~15 grams of Flos Inulae, 15~25 grams of Rhizoma Atractylodis, 15~25 grams of the Rhizoma Atractylodis Macrocephalaes, 10~20 grams of Radix Astragali, 10~20 grams of Radix Codonopsis, 5~15 grams of Fructus Lycii, 5~15 grams of Semen Myristicaes, 5~15 grams of Bulbus Fritillariae Thunbergii, 5~15 grams of Os Sepiae, 5~15 grams of Fructus Akebiaes, 3~7 grams of Aspongopuss, 5~15 grams of Rhizoma Polygonatis, 3~9 grams of Fructus Aurantiis, 3~9 grams of Cortex Magnoliae Officinalis.
2, the weight portion of the medicine material of this treatment reflux gastritis is: 5~15 grams of Haematitums, 5~15 grams of Flos Inulae, 15~25 grams of Rhizoma Atractylodis, 15~25 grams of the Rhizoma Atractylodis Macrocephalaes, 10~20 grams of Radix Astragali, 10~20 grams of Radix Codonopsis, 5~15 grams of Fructus Lycii, 5~15 grams of Semen Myristicaes, 5~15 grams of Bulbus Fritillariae Thunbergii, 5~15 grams of Os Sepiae, 5~15 grams of Fructus Akebiaes, 3~7 grams of Aspongopuss, 5~15 grams of Rhizoma Polygonatis, 3~9 grams of Fructus Aurantiis, 3~9 grams of Cortex Magnoliae Officinalis.
3, the weight portion of the medicine material of this treatment reflux gastritis is: 5~15 grams of Haematitums, 5~15 grams of Flos Inulae, 15~25 grams of Rhizoma Atractylodis, 15~25 grams of the Rhizoma Atractylodis Macrocephalaes, 10~20 grams of Radix Astragali, 10~20 grams of Radix Codonopsis, 5~15 grams of Fructus Lycii, 5~15 grams of Semen Myristicaes, 5~15 grams of Bulbus Fritillariae Thunbergii, 5~15 grams of Os Sepiae, 5~15 grams of Fructus Akebiaes, 3~7 grams of Aspongopuss, 5~15 grams of Rhizoma Polygonatis, 3~9 grams of Fructus Aurantiis, 3~9 grams of Cortex Magnoliae Officinalis.
The all raw materials of the present invention are commercially available.
The production method of the embodiment of the present invention for will above-mentioned each medicine and together with, 100 degrees Celsius of following oven dry, pulverize, 200 mesh sieves, honey is ball, 9 gram of 1 ball, with yellow waxed paper wrap up patent medicine.
The present invention's pharmacy as a large amount of in need can increase material quantity by above-mentioned weight ratio.
Usage of the present invention is 1 ball bfore meals, says and takes 3 times, and warm water is sent down, and 15 days 1 courses for the treatment of, take effect 2~3 courses for the treatment of.
Pharmacology analysis: reflux gastritis performance characteristic is that upper abdomen distension does not relax, time have pantothenic acid, heartburn, have the hiccups, after the meal more so, insufficiency of the spleen leading to overabundance of dampness, defecates unable, weak pulse is unable.The spleen reinforcing stomach reinforcing symptom that can make to backflow alleviates.The Rhizoma Atractylodis Macrocephalae, Radix Codonopsis are usually used in warming YANG to expel cold, Rhizoma Atractylodis, Fructus Aurantii, Cortex Magnoliae Officinalis its can drying dampness to eliminate phlegm, again can regulating the stomach and sending down the abnormal ascending QI, get the merit of its regulating the stomach and sending down the abnormal ascending QI, for clearing away heat and resolving stagnation of food, spleen reinforcing stomach reinforcing.Os Sepiae is applicable to treat many, the heartburn persons of gastric acid.The spleen reinforcing stomach reinforcing symptom of backflowing alleviates, so this medicine can be treated reflux gastritis.
The present invention, by probation, to more than 200 routine reflux gastritis treatments, cures 190 examples, effective 8 examples, invalid 2 examples.
Zhao, man, 40 years old, because I do not note having a meal at regular time and quantity, long-term hungry after a full meal, work is not taken a good rest, and obtains reflux gastritis, very painful, with two courses for the treatment of of this Drug therapy, has just obviously built up.
Chen, man, 20 years old, Yi university studied, stay up late all day, do not take a good rest, and do not note having a meal, and obtained reflux gastritis, serious impact study.Take this medicine 15 days, symptom has just alleviated.Held on again afterwards and eaten 1 course for the treatment of, just complete good.
Beam, female, 50 years old, worn with age, I was lazy again, do not note having a meal on time, obtain reflux gastritis.Serious impact healthy.Take this medicine 1 month, just thoroughly cured.
Poplar, female, 35 years old, due in the work of private factory, work under bad environment, labor intensity is large, overworks, and health consume unconsciously, works together exhausted, obtains reflux gastritis, takes 3 courses for the treatment of of this medicine, just there is no symptom.
Lee, the work of Nan, 50Sui, research unit, often stays up late, heart failure.Obtained reflux gastritis, by this Drug therapy 1 month, be just clearly better.
Claims (5)
1. treat a medicine for reflux gastritis, it is characterized in that the weight portion of its raw material is: 5~15 grams of Haematitums, 5~15 grams of Flos Inulae, 15~25 grams of Rhizoma Atractylodis, 15~25 grams of the Rhizoma Atractylodis Macrocephalaes, 10~20 grams of Radix Astragali, 10~20 grams of Radix Codonopsis, 5~15 grams of Fructus Lycii, 5~15 grams of Semen Myristicaes, 5~15 grams of Bulbus Fritillariae Thunbergii, 5~15 grams of Os Sepiae, 5~15 grams of Fructus Akebiaes, 3~7 grams of Aspongopuss, 5~15 grams of Rhizoma Polygonatis, 3~9 grams of Fructus Aurantiis, 3~9 grams of Cortex Magnoliae Officinalis; Above-mentioned each medicine with together with, 100 degrees Celsius of following oven dry, pulverize, cross 200 mesh sieves, honey is ball, 9 gram of 1 ball, with yellow waxed paper wrap up patent medicine.
2. the medicine for the treatment of reflux gastritis according to claim 1, is characterized in that the weight portion of its raw material is: 5 grams of Haematitums, 5 grams of Flos Inulae, 15 grams of Rhizoma Atractylodis, 15 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Radix Astragali, 10 grams of Radix Codonopsis, 5 grams of Fructus Lycii, 5 grams of Semen Myristicaes, 5 grams of Bulbus Fritillariae Thunbergii, 5 grams of Os Sepiae, 5 grams of Fructus Akebiaes, 3 grams of Aspongopuss, 5 grams of Rhizoma Polygonatis, 3 grams of Fructus Aurantiis, 3 grams of Cortex Magnoliae Officinalis.
3. the medicine for the treatment of reflux gastritis according to claim 1, is characterized in that the weight portion of its raw material is: 10 grams of Haematitums, 10 grams of Flos Inulae, 20 grams of Rhizoma Atractylodis, 20 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams of Radix Astragali, 15 grams of Radix Codonopsis, 10 grams of Fructus Lycii, 10 grams of Semen Myristicaes, 10 grams of Bulbus Fritillariae Thunbergii, 10 grams of Os Sepiae, 10 grams of Fructus Akebiaes, 5 grams of Aspongopuss, 10 grams of Rhizoma Polygonatis, 6 grams of Fructus Aurantiis, 6 grams of Cortex Magnoliae Officinalis.
4. the medicine for the treatment of reflux gastritis according to claim 1, is characterized in that the weight portion of its raw material is: 15 grams of Haematitums, 15 grams of Flos Inulae, 25 grams of Rhizoma Atractylodis, 25 grams of the Rhizoma Atractylodis Macrocephalaes, 20 grams of Radix Astragali, 20 grams of Radix Codonopsis, 15 grams of Fructus Lycii, 15 grams of Semen Myristicaes, 15 grams of Bulbus Fritillariae Thunbergii, 15 grams of Os Sepiae, 15 grams of Fructus Akebiaes, 7 grams of Aspongopuss, 15 grams of Rhizoma Polygonatis, 9 grams of Fructus Aurantiis, 9 grams of Cortex Magnoliae Officinalis.
5. the production method of the medicine of the treatment reflux gastritis as described in claim 1~4 any one claim, it is characterized in that its production method be above-mentioned each medicine with together with, 100 degrees Celsius of following oven dry, pulverize, cross 200 mesh sieves, honey is ball, 9 gram of 1 ball, with yellow waxed paper parcel patent medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210120673.1A CN102670972B (en) | 2012-04-21 | 2012-04-21 | Drug for treating reflux gastritis and production method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210120673.1A CN102670972B (en) | 2012-04-21 | 2012-04-21 | Drug for treating reflux gastritis and production method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102670972A CN102670972A (en) | 2012-09-19 |
CN102670972B true CN102670972B (en) | 2014-02-12 |
Family
ID=46803957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210120673.1A Expired - Fee Related CN102670972B (en) | 2012-04-21 | 2012-04-21 | Drug for treating reflux gastritis and production method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102670972B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104055942A (en) * | 2013-11-26 | 2014-09-24 | 申志恩 | Four vine bone-strengthening pill and production method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072938C (en) * | 1996-08-23 | 2001-10-17 | 李懋 | Traditional chinese medicine for curing gastric disease |
-
2012
- 2012-04-21 CN CN201210120673.1A patent/CN102670972B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102670972A (en) | 2012-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101703734B (en) | Chinese medicinal preparation for treating gastrosis | |
CN103127378B (en) | Chinese medicinal composition for treating rheumatic heart disease | |
CN101496887B (en) | Medicament for treating acute hot, itching and wet severe type and chronic urticaria | |
CN100542596C (en) | A kind of medicine for the treatment of chronic gastritis, peptic ulcer | |
CN101947304A (en) | Traditional Chinese medicinal composition for treating cold gastroenteropathy | |
CN103006979B (en) | Chinese medicinal composition for treating nephrotic edema | |
CN103272096A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
CN103191391B (en) | Tradtional Chinese medicine for treating chronic gastritis | |
CN104721792A (en) | Traditional Chinese medicine composition for treating intolerance of cold | |
CN102670972B (en) | Drug for treating reflux gastritis and production method thereof | |
CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
CN104367965A (en) | Traditional Chinese medicine composition for treating obesity | |
CN102716399A (en) | TCM decoction for curing phthises by taking one dose per day | |
CN102784296B (en) | Fructus trichosanthis oral liquid | |
CN105288417A (en) | Traditional Chinese medicine for treating infantile malnutrition | |
CN102772621B (en) | Traditional Chinese medicine formula for treating qi-deficiency rectocele | |
CN102397403A (en) | Medicine for treating kidney dysfunction | |
CN102579718A (en) | Chinese medicament for treating kidney qi deficiency type prostatitis | |
CN100998818B (en) | Oral Chinese medicine for treating damp-heat impairment of yang night sweating | |
CN101085329A (en) | Traditional Chinese medicine healthy prescription capable of tonifying kidney and enlivening spleen | |
CN105148175A (en) | Chinese herbal decoction for stimulating appetite and removing food retention | |
CN105663981A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
CN104147415A (en) | Chinese traditional medicine for treating chronic gastroenteritis | |
CN104096210A (en) | Medicine for treating chest distress and pain and gastritis and production method of medicine | |
CN105311298A (en) | Traditional Chinese medicine for treating obesity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140212 Termination date: 20150421 |
|
EXPY | Termination of patent right or utility model |